Eli Lilly to acquire cancer drug maker Kelonia in deal worth up to $7 billion
Eli Lilly will acquire biotech company Kelonia Therapeutics in a deal worth up to $7 billion, the company said Monday.…
Centessa Pharmaceuticals PLC
Eli Lilly to acquire Centessa and drugs for sleep disorders
Eli Lilly has agreed to pay up to $7.8 billion to acquire Centessa Pharmaceuticals and its experimental drug for excessive…
Stocks Soar on Hope for Iran War Resolution; In addition, Lilly suffers a big change in sleep disorders
Every weekday, the CNBC Investing Club with Jim Cramer publishes Homestretch, a helpful afternoon update just in time for the…